Allozymes

Singapore, Singapore

Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries

$15.0M raised

Aug 2023

Series A

Top Investors

Entrepreneurs FirstSOSVSeventure PartnersXora InnovationTranspose Platform Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Allozymes raised?

Allozymes has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.

Who are Allozymes's investors?

Allozymes's investors include Entrepreneurs First, SOSV, Seventure Partners, Xora Innovation, Transpose Platform Management.

Where is Allozymes headquartered?

Allozymes is headquartered in Singapore, Singapore.

What does Allozymes do?

Allozymes is a biotech company that accelerating enzyme evolution for the sustainable future of industries

What stage is Allozymes at?

Allozymes is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 7, 2023.

MLA

"Allozymes — Funding & Investors." VCBacked, August 7, 2023, https://www.vcbacked.co/company/allozymes. Accessed June 4, 2026.

APA

VCBacked. (2023). Allozymes — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/allozymes

Wikipedia (cite web)

{{cite web |title=Allozymes — Funding & Investors |url=https://www.vcbacked.co/company/allozymes |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 7, 2023.